Literature DB >> 15797623

Effects of 3-methylcholanthrene on the transcriptional activity and mRNA accumulation of the oncogene hWAPL.

Masahiko Kuroda1, Kosuke Oikawa, Keiichi Yoshida, Aya Takeuchi, Masaru Takeuchi, Masahiko Usui, Akihiro Umezawa, Kiyoshi Mukai.   

Abstract

hWAPL is a human oncogene associated with uterine cervical cancer. Here, we demonstrate that hWAPL transcription is induced by 3-methylcholanthrene (3-MC) in the cervical carcinoma-derived cell line SiHa. hWAPL transcription was analyzed with evaluation of the mRNA and heterogeneous nuclear RNA (hnRNA) levels by quantitative real time PCR analysis. Flow cytometric analysis suggested that the alteration of hWAPL mRNA levels is independent of cell cycle profile. We also found that DMSO and some components of FBS affect hWAPL transcription. Interestingly, when the aryl hydrocarbon receptor (AhR) function was inhibited by alpha-naphthoflavone (ANF), the induction of hWAPL transcription by 3-MC was greater than that in AhR-functioning normal cells. These observations suggest that there are complex mechanisms regulating the transcription of hWAPL. Furthermore, mRNA level of a mouse homolog of hWAPL in mouse uterus was induced by 3-MC injection into the abdominal cavity. Thus, some effects from 3-MC exposure on uterus may be mediated by the unscheduled overexpression of hWAPL.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797623     DOI: 10.1016/j.canlet.2004.08.006

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  8 in total

1.  Importin 7 and exportin 1 link c-Myc and p53 to regulation of ribosomal biogenesis.

Authors:  Lior Golomb; Debora Rosa Bublik; Sylvia Wilder; Reinat Nevo; Vladimir Kiss; Kristina Grabusic; Sinisa Volarevic; Moshe Oren
Journal:  Mol Cell       Date:  2012-01-27       Impact factor: 17.970

2.  Clinical significance of hWAPL polymorphisms in the risk of cervical carcinogenesis.

Authors:  Osamu Nunobiki; Daisuke Sano; Sakae Hata; Toshitada Ogasawara; Masatsugu Ueda
Journal:  Hum Cell       Date:  2018-01-23       Impact factor: 4.174

3.  Relationship between hWAPL polymorphisms and cervical cancer susceptibility.

Authors:  Li Li; Gen-Long Jiao; Shuang Qin; Qing Xiao
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  RNF20 and USP44 regulate stem cell differentiation by modulating H2B monoubiquitylation.

Authors:  Gilad Fuchs; Efrat Shema; Rita Vesterman; Eran Kotler; Zohar Wolchinsky; Sylvia Wilder; Lior Golomb; Ariel Pribluda; Feng Zhang; Mahmood Haj-Yahya; Ester Feldmesser; Ashraf Brik; Xiaochun Yu; Jacob Hanna; Daniel Aberdam; Eytan Domany; Moshe Oren
Journal:  Mol Cell       Date:  2012-06-08       Impact factor: 17.970

5.  p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation.

Authors:  Ruth Scherz-Shouval; Hilla Weidberg; Chagay Gonen; Sylvia Wilder; Zvulun Elazar; Moshe Oren
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

6.  RNF20 inhibits TFIIS-facilitated transcriptional elongation to suppress pro-oncogenic gene expression.

Authors:  Efrat Shema; Jaehoon Kim; Robert G Roeder; Moshe Oren
Journal:  Mol Cell       Date:  2011-05-20       Impact factor: 17.970

7.  Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Authors:  Tomer Cooks; Ioannis S Pateras; Ohad Tarcic; Hilla Solomon; Aaron J Schetter; Sylvia Wilder; Guillermina Lozano; Eli Pikarsky; Tim Forshew; Nitzan Rosenfeld; Nitzan Rozenfeld; Noam Harpaz; Steven Itzkowitz; Curtis C Harris; Varda Rotter; Vassilis G Gorgoulis; Moshe Oren
Journal:  Cancer Cell       Date:  2013-05-13       Impact factor: 31.743

8.  The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.

Authors:  Efrat Shema; Itay Tirosh; Yael Aylon; Jing Huang; Chaoyang Ye; Neta Moskovits; Nina Raver-Shapira; Neri Minsky; Judith Pirngruber; Gabi Tarcic; Pavla Hublarova; Lilach Moyal; Mali Gana-Weisz; Yosef Shiloh; Yossef Yarden; Steven A Johnsen; Borivoj Vojtesek; Shelley L Berger; Moshe Oren
Journal:  Genes Dev       Date:  2008-10-01       Impact factor: 11.361

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.